Dr. Amit Grover, a scientist at AstraZeneca, stated on July 27, 2026, that the gut microbiome plays a significant role in the aging process and the development of chronic inflammation.
Research presented at Maharshi Dayanand University indicates that older individuals exhibit an alteration in microbial diversity and a higher ratio of myeloid cells compared to lymphoid cells, impacting immunity.
The study suggests that immunotherapy and T-cell activation could be utilized to combat age-related malignancies, noting that genetic mutations also contribute to health complications during the aging process.